Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 1

Conditions

Prostatic Neoplasms 292Urinary Bladder Neoplasms 39Neoplasm Metastasis 35Carcinoma, Non-Small-Cell Lung 24Carcinoma, Transitional Cell 23Neoplasms 21Breast Neoplasms 20Lung Neoplasms 13Carcinoma, Renal Cell 13Ovarian Neoplasms 12Stomach Neoplasms 11Squamous Cell Carcinoma of Head and Neck 11Non-Muscle Invasive Bladder Neoplasms 10Melanoma 9Small Cell Lung Carcinoma 7Salivary Gland Neoplasms 7Prostatic Neoplasms, Castration-Resistant 7Head and Neck Neoplasms 7Esthesioneuroblastoma, Olfactory 7Esophageal Neoplasms 7Colorectal Neoplasms 7Urethral Neoplasms 6Uterine Cervical Neoplasms 5Triple Negative Breast Neoplasms 5Prostate Cancer Metastatic 5Pancreatic Neoplasms 5Metastatic Castration-resistant Prostate Cancer 5Kidney Neoplasms 5Adenocarcinoma 5Sarcoma 4

Interventions

Analgesia 6Zoledronic Acid 5Prednisone 4Docetaxel 4Radiotherapy 3cabozantinib 2Psychiatric Rehabilitation 2Mitoxantrone 2Lidocaine 2Filgrastim 2Cystoscopy 2tandutinib 1strontium chloride 1pegfilgrastim 1Vitamin D 1Vertebroplasty 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Strontium-89 1Samarium-153 1Radium-223 1Radiation 1Oxygen 1Observation 1Nitrous Oxide 1Morphine 1Midazolam 1Methadone 1Mepivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Pain × Docetaxel × Genitourinary × Clear all
NCT00003781 2017-04-28

Docetaxel in Treating Patients With Stage IV Prostate Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
25 enrolled
Genitourinary

Pain, Prostatic Neoplasms

NCT00503984 2016-06-09

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

University of Miami

Phase 1/2 Terminated
22 enrolled 16 charts
Genitourinary

Pain, Prostatic Neoplasms

NCT00005960 2013-12-04

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
Genitourinary

Pain, Prostatic Neoplasms

NCT00796458 2013-08-12

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡